According to Latest Study, the global market for Cannabinoid Derived Pharmaceutical should grow from US$ 884 million in 2022 to US$ 1877.4 million by 2029, with a CAGR of 12.4% for the period of 2024-2030.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Cannabinoid Derived Pharmaceutical market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Cannabinoid Derived Pharmaceutical market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

By segment, Epilepsy grew percent to account for percent of the total market sales, and Migraine grew percent.

This report studies and analyses global Cannabinoid Derived Pharmaceutical status and future trends, helps the client to determine the Cannabinoid Derived Pharmaceutical market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cannabinoid Derived Pharmaceutical, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Cannabinoid Derived Pharmaceutical market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Cannabinoid Derived Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Cannabinoid Derived Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Cannabinoid Derived Pharmaceutical key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Cannabinoid Derived Pharmaceutical key producing regions, capacity, production, and year over year growth

(6) Cannabinoid Derived Pharmaceutical industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Cara Therapeutics Inc

Arena Pharmaceuticals

Cannabics Pharmaceuticals Inc

Echo Pharmaceuticals

Gw Pharmaceuticals

Inmed Pharmaceuticals

Insys Therapeutics Inc

Larapharm

Mgc Pharmaceuticals Ltd

One World Cannabis

Orpheus Medica

Receptor Life Sciences

Respirerx Pharmaceuticals

Tetra Bio-Pharma

Cardiol Therapeutics

United Cannabis Corporation

Zynerba Pharmaceuticals

Market segment by Type, covers

Cannabinoid Receptor Type 1 (CB1)

Cannabinoid Receptor Type 2 (CB2)

Others

Market segment by Application, can be divided into

Epilepsy

Migraine

Multiple Sclerosis

Others

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Cannabinoid Derived Pharmaceutical product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Cannabinoid Derived Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Cannabinoid Derived Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Cannabinoid Derived Pharmaceutical, percent & CAGR, 2018-2029

Chapter 5: Cannabinoid Derived Pharmaceutical industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Cannabinoid Derived Pharmaceutical Definition

1.2 Global Cannabinoid Derived Pharmaceutical Market Size and Forecast

1.2.1 By Consumption Value, Global Cannabinoid Derived Pharmaceutical Market Size，2019-2030

1.2.2 By Sales Quantity, Global Cannabinoid Derived Pharmaceutical Market Size，2019-2030

1.2.3 Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP)，2019-2030

1.3 China Cannabinoid Derived Pharmaceutical Market Size and Forecast

1.3.1 By Consumption Value, China Cannabinoid Derived Pharmaceutical Market Size，2019-2030

1.3.2 By Sales Quantity, China Cannabinoid Derived Pharmaceutical Market Size，2019-2030

1.3.3 China Cannabinoid Derived Pharmaceutical Average Selling Price (ASP)， 2019-2030

1.4 Share of China Cannabinoid Derived Pharmaceutical Market with Respect to the Global Market

1.4.1 By Consumption Value, China Cannabinoid Derived Pharmaceutical Market Share in Global, 2019-2030

1.4.2 By Sales Quantity, China Cannabinoid Derived Pharmaceutical Market Share in Global, 2019-2030

1.4.3 Cannabinoid Derived Pharmaceutical Market Size: China VS Global, 2019-2030

1.5 Cannabinoid Derived Pharmaceutical Market Dynamics

1.5.1 Cannabinoid Derived Pharmaceutical Market Drivers

1.5.2 Cannabinoid Derived Pharmaceutical Market Restraints

1.5.3 Cannabinoid Derived Pharmaceutical Industry Trends

1.5.4 Cannabinoid Derived Pharmaceutical Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Cannabinoid Derived Pharmaceutical, Global Market Share by Company, 2019-2024

2.2 By Sales Quantity of Cannabinoid Derived Pharmaceutical, Global Market Share by Company, 2019-2024

2.3 Cannabinoid Derived Pharmaceutical Average Selling Price (ASP) by Company, 2019-2024

2.4 Global Cannabinoid Derived Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Cannabinoid Derived Pharmaceutical Concentration Ratio

2.6 Global Cannabinoid Derived Pharmaceutical Mergers & Acquisitions, Expansion Plans

2.7 Global Cannabinoid Derived Pharmaceutical Manufacturers Product Type

2.8 Head Office and Cannabinoid Derived Pharmaceutical Production Site of Key Manufacturer

2.9 Cannabinoid Derived Pharmaceutical Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Cannabinoid Derived Pharmaceutical, China Market Share by Company, 2019-2024

3.2 By Sales Quantity of Cannabinoid Derived Pharmaceutical, China Market Share by Company, 2019-2024

3.3 China Cannabinoid Derived Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Cannabinoid Derived Pharmaceutical Capacity, Output and Capacity Utilization, 2019-2030

4.2 Global Cannabinoid Derived Pharmaceutical Capacity by Region

4.3 Global Cannabinoid Derived Pharmaceutical Production & Forecast by Region, 2019 VS 2024 VS 2030

4.4 Global Cannabinoid Derived Pharmaceutical Production by Region, 2019-2030

4.5 Global Cannabinoid Derived Pharmaceutical Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Cannabinoid Derived Pharmaceutical Industry Chain

5.2 Cannabinoid Derived Pharmaceutical Upstream Analysis

5.2.1 Cannabinoid Derived Pharmaceutical Core Raw Materials

5.2.2 Main Manufacturers of Cannabinoid Derived Pharmaceutical Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Cannabinoid Derived Pharmaceutical Production Mode

5.6 Cannabinoid Derived Pharmaceutical Procurement Model

5.7 Cannabinoid Derived Pharmaceutical Industry Sales Model and Sales Channels

5.7.1 Cannabinoid Derived Pharmaceutical Sales Model

5.7.2 Cannabinoid Derived Pharmaceutical Typical Distributors

6 Sights by Type

6.1 Cannabinoid Derived Pharmaceutical Classification

6.1.1 Cannabinoid Receptor Type 1 (CB1)

6.1.2 Cannabinoid Receptor Type 2 (CB2)

6.1.3 Others

6.2 By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030

6.4 By Type, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030

6.5 By Type, Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), 2019-2030

7 Sights by Application

7.1 Cannabinoid Derived Pharmaceutical Segment by Application

7.1.1 Epilepsy

7.1.2 Migraine

7.1.3 Multiple Sclerosis

7.1.4 Others

7.2 By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030

7.4 By Application, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030

7.5 By Application, Global Cannabinoid Derived Pharmaceutical Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019 VS 2024 VS 2030

8.2 By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030

8.3 By Region, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030

8.4 North America

8.4.1 North America Cannabinoid Derived Pharmaceutical & Forecasts, 2019-2030

8.4.2 By Country, North America Cannabinoid Derived Pharmaceutical Market Size Market Share

8.5 Europe

8.5.1 Europe Cannabinoid Derived Pharmaceutical Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Cannabinoid Derived Pharmaceutical Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Cannabinoid Derived Pharmaceutical Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Cannabinoid Derived Pharmaceutical Market Size Market Share

8.7 South America

8.7.1 South America Cannabinoid Derived Pharmaceutical Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Cannabinoid Derived Pharmaceutical Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Cannabinoid Derived Pharmaceutical Market Size & CAGR, 2019 VS 2024 VS 2030

9.2 By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030

9.3 By Country, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030

9.4 U.S.

9.4.1 U.S. Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.4.2 By Type, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.5.2 By Type, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.6.2 By Type, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.7.2 By Type, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.8.2 By Type, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.9.2 By Type, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.10.2 By Type, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Cannabinoid Derived Pharmaceutical Market Size, 2019-2030

9.11.2 By Type, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Cara Therapeutics Inc

10.1.1 Cara Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

10.1.2 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Cara Therapeutics Inc Company Profile and Main Business

10.1.5 Cara Therapeutics Inc Recent Developments

10.2 Arena Pharmaceuticals

10.2.1 Arena Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.2.2 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Arena Pharmaceuticals Company Profile and Main Business

10.2.5 Arena Pharmaceuticals Recent Developments

10.3 Cannabics Pharmaceuticals Inc

10.3.1 Cannabics Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position

10.3.2 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Cannabics Pharmaceuticals Inc Company Profile and Main Business

10.3.5 Cannabics Pharmaceuticals Inc Recent Developments

10.4 Echo Pharmaceuticals

10.4.1 Echo Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.4.2 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Echo Pharmaceuticals Company Profile and Main Business

10.4.5 Echo Pharmaceuticals Recent Developments

10.5 Gw Pharmaceuticals

10.5.1 Gw Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.5.2 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Gw Pharmaceuticals Company Profile and Main Business

10.5.5 Gw Pharmaceuticals Recent Developments

10.6 Inmed Pharmaceuticals

10.6.1 Inmed Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.6.2 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Inmed Pharmaceuticals Company Profile and Main Business

10.6.5 Inmed Pharmaceuticals Recent Developments

10.7 Insys Therapeutics Inc

10.7.1 Insys Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

10.7.2 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Insys Therapeutics Inc Company Profile and Main Business

10.7.5 Insys Therapeutics Inc Recent Developments

10.8 Larapharm

10.8.1 Larapharm Company Information, Head Office, Market Area, and Industry Position

10.8.2 Larapharm Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.8.3 Larapharm Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Larapharm Company Profile and Main Business

10.8.5 Larapharm Recent Developments

10.9 Mgc Pharmaceuticals Ltd

10.9.1 Mgc Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position

10.9.2 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Mgc Pharmaceuticals Ltd Company Profile and Main Business

10.9.5 Mgc Pharmaceuticals Ltd Recent Developments

10.10 One World Cannabis

10.10.1 One World Cannabis Company Information, Head Office, Market Area, and Industry Position

10.10.2 One World Cannabis Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.10.4 One World Cannabis Company Profile and Main Business

10.10.5 One World Cannabis Recent Developments

10.11 Orpheus Medica

10.11.1 Orpheus Medica Company Information, Head Office, Market Area, and Industry Position

10.11.2 Orpheus Medica Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Orpheus Medica Company Profile and Main Business

10.11.5 Orpheus Medica Recent Developments

10.12 Receptor Life Sciences

10.12.1 Receptor Life Sciences Company Information, Head Office, Market Area, and Industry Position

10.12.2 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Receptor Life Sciences Company Profile and Main Business

10.12.5 Receptor Life Sciences Recent Developments

10.13 Respirerx Pharmaceuticals

10.13.1 Respirerx Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.13.2 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Respirerx Pharmaceuticals Company Profile and Main Business

10.13.5 Respirerx Pharmaceuticals Recent Developments

10.14 Tetra Bio-Pharma

10.14.1 Tetra Bio-Pharma Company Information, Head Office, Market Area, and Industry Position

10.14.2 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Tetra Bio-Pharma Company Profile and Main Business

10.14.5 Tetra Bio-Pharma Recent Developments

10.15 Cardiol Therapeutics

10.15.1 Cardiol Therapeutics Company Information, Head Office, Market Area, and Industry Position

10.15.2 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.15.4 Cardiol Therapeutics Company Profile and Main Business

10.15.5 Cardiol Therapeutics Recent Developments

10.16 United Cannabis Corporation

10.16.1 United Cannabis Corporation Company Information, Head Office, Market Area, and Industry Position

10.16.2 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.16.4 United Cannabis Corporation Company Profile and Main Business

10.16.5 United Cannabis Corporation Recent Developments

10.17 Zynerba Pharmaceuticals

10.17.1 Zynerba Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.17.2 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

10.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.17.4 Zynerba Pharmaceuticals Company Profile and Main Business

10.17.5 Zynerba Pharmaceuticals Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Cannabinoid Derived Pharmaceutical Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Cannabinoid Derived Pharmaceutical Market Restraints

Table 3. Cannabinoid Derived Pharmaceutical Market Trends

Table 4. Cannabinoid Derived Pharmaceutical Industry Policy

Table 5. Global Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Cannabinoid Derived Pharmaceutical Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Cannabinoid Derived Pharmaceutical Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Cannabinoid Derived Pharmaceutical Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cannabinoid Derived Pharmaceutical Mergers & Acquisitions, Expansion Plans

Table 12. Global Cannabinoid Derived Pharmaceutical Manufacturers Product Type

Table 13. Head Office and Cannabinoid Derived Pharmaceutical Production Site of Key Manufacturer

Table 14. Cannabinoid Derived Pharmaceutical Capacity of Major Manufacturers and Future Plan

Table 15. China Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Cannabinoid Derived Pharmaceutical Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Cannabinoid Derived Pharmaceutical Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Cannabinoid Derived Pharmaceutical Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Cannabinoid Derived Pharmaceutical Production by Region, 2019-2024, (K Units)

Table 20. Global Cannabinoid Derived Pharmaceutical Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Cannabinoid Derived Pharmaceutical Upstream (Raw Materials)

Table 22. Global Cannabinoid Derived Pharmaceutical Typical Customers

Table 23. Cannabinoid Derived Pharmaceutical Typical Distributors

Table 24. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Table 34. Cara Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

Table 35. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 36. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Cara Therapeutics Inc Company Profile and Main Business

Table 38. Cara Therapeutics Inc Recent Developments

Table 39. Arena Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 40. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 41. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Arena Pharmaceuticals Company Profile and Main Business

Table 43. Arena Pharmaceuticals Recent Developments

Table 44. Cannabics Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position

Table 45. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 46. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Cannabics Pharmaceuticals Inc Company Profile and Main Business

Table 48. Cannabics Pharmaceuticals Inc Recent Developments

Table 49. Echo Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 50. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 51. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Echo Pharmaceuticals Company Profile and Main Business

Table 53. Echo Pharmaceuticals Recent Developments

Table 54. Gw Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 55. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 56. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Gw Pharmaceuticals Company Profile and Main Business

Table 58. Gw Pharmaceuticals Recent Developments

Table 59. Inmed Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 60. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 61. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Inmed Pharmaceuticals Company Profile and Main Business

Table 63. Inmed Pharmaceuticals Recent Developments

Table 64. Insys Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

Table 65. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 66. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Insys Therapeutics Inc Company Profile and Main Business

Table 68. Insys Therapeutics Inc Recent Developments

Table 69. Larapharm Company Information, Head Office, Market Area, and Industry Position

Table 70. Larapharm Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 71. Larapharm Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Larapharm Company Profile and Main Business

Table 73. Larapharm Recent Developments

Table 74. Mgc Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position

Table 75. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 76. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Mgc Pharmaceuticals Ltd Company Profile and Main Business

Table 78. Mgc Pharmaceuticals Ltd Recent Developments

Table 79. One World Cannabis Company Information, Head Office, Market Area, and Industry Position

Table 80. One World Cannabis Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 81. One World Cannabis Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. One World Cannabis Company Profile and Main Business

Table 83. One World Cannabis Recent Developments

Table 84. Orpheus Medica Company Information, Head Office, Market Area, and Industry Position

Table 85. Orpheus Medica Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 86. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Orpheus Medica Company Profile and Main Business

Table 88. Orpheus Medica Recent Developments

Table 89. Receptor Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 90. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 91. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Receptor Life Sciences Company Profile and Main Business

Table 93. Receptor Life Sciences Recent Developments

Table 94. Respirerx Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 95. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 96. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Respirerx Pharmaceuticals Company Profile and Main Business

Table 98. Respirerx Pharmaceuticals Recent Developments

Table 99. Tetra Bio-Pharma Company Information, Head Office, Market Area, and Industry Position

Table 100. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 101. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Tetra Bio-Pharma Company Profile and Main Business

Table 103. Tetra Bio-Pharma Recent Developments

Table 104. Cardiol Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 105. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 106. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Cardiol Therapeutics Company Profile and Main Business

Table 108. Cardiol Therapeutics Recent Developments

Table 109. United Cannabis Corporation Company Information, Head Office, Market Area, and Industry Position

Table 110. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 111. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. United Cannabis Corporation Company Profile and Main Business

Table 113. United Cannabis Corporation Recent Developments

Table 114. Zynerba Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 115. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 116. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Zynerba Pharmaceuticals Company Profile and Main Business

Table 118. Zynerba Pharmaceuticals Recent Developments

List of Figures

Figure 1. Cannabinoid Derived Pharmaceutical Picture

Figure 2. Global Cannabinoid Derived Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Cannabinoid Derived Pharmaceutical Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Cannabinoid Derived Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Cannabinoid Derived Pharmaceutical Sales Quantity (K Units) & (2019-2030)

Figure 7. China Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Cannabinoid Derived Pharmaceutical Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Cannabinoid Derived Pharmaceutical Market Share of Global, 2019-2030

Figure 10. Global Cannabinoid Derived Pharmaceutical Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Cannabinoid Derived Pharmaceutical Key Participants, Market Share, 2022

Figure 12. Global Cannabinoid Derived Pharmaceutical Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Cannabinoid Derived Pharmaceutical Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Cannabinoid Derived Pharmaceutical Production Market Share & Forecast by Region, 2019-2030

Figure 15. Cannabinoid Derived Pharmaceutical Industry Chain

Figure 16. Cannabinoid Derived Pharmaceutical Procurement Model

Figure 17. Cannabinoid Derived Pharmaceutical Sales Model

Figure 18. Cannabinoid Derived Pharmaceutical Sales Channels, Direct Sales, and Distribution

Figure 19. Cannabinoid Receptor Type 1 (CB1)

Figure 20. Cannabinoid Receptor Type 2 (CB2)

Figure 21. Others

Figure 22. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 23. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 24. By Type, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 25. By Type, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 26. By Type, Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 27. Epilepsy

Figure 28. Migraine

Figure 29. Multiple Sclerosis

Figure 30. Others

Figure 31. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 32. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 33. By Application, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 34. By Application, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 35. By Application, Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 36. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 37. By Region, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 38. North America Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 39. By Country, North America Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 40. Europe Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, Europe Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 42. Asia Pacific Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 43. By Country/Region, Asia Pacific Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 44. South America Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, South America Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 46. Middle East & Africa Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 47. U.S. Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 48. By Type, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 50. Europe Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 51. By Type, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 53. China Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 54. By Type, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 56. Japan Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 57. By Type, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 59. South Korea Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 60. By Type, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 62. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 63. By Type, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 65. India Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 66. By Type, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 68. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 69. By Type, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)